Shareholders' Deficit |
3 Months Ended |
|---|---|
Mar. 31, 2025 | |
| Shareholders’ Deficit [Abstract] | |
| SHAREHOLDERS' DEFICIT | 7. SHAREHOLDERS’ DEFICIT
Common Stock
As of March 31, 2025 and December 31, 2024, the Company had 100,000,000 authorized shares of common stock, respectively, at a par value of $0.01. The Company had 7,903,850 common shares issued and outstanding, as of March 31, 2025 and December 31, 2024, respectively. Each Common share is entitled to one vote.
On February 7, 2025, the Board approved and implemented a reverse stock split ratio of 1-for-2.6, which provided that every 2.6 shares of its issued and outstanding Common Stock were automatically combined into one issued and outstanding share of Common Stock, without any change in the par value per share. All share and per share amounts in the accompanying unaudited condensed financial statements and footnotes have been retrospectively adjusted for the reverse split
Preferred Stock
On December 5, 2023, the Company authorized 10,000,000 shares of preferred stock with a par value of $0.01. The rights and preferences of preferred shareholders have not been determined as of the date of filing. The Company had no preferred shares issued or outstanding as of March 31, 2025 and December 31, 2024, respectively. |